Targeted Protein Degraders: Key strategies to Maximize VC Funding and Clinical Success
Summary: In this webinar, experts will explore the current investment and clinical landscape of Targeted Protein Degraders.
Small Molecule Orphan Drugs: Status Quo, Challenges, and Perspectives
Summary: Experts explore the challenges of orphan drug development and manufacturing and will discuss how the industry is leveraging strategic partnerships to help mitigate these challenges to create a viable orphan drug business model.
Targeted Protein Degraders: Through the Lens of the Innovation, Developability, and CMC Challenges
Summary: Experts review the trends and challenges associated with the rational design of targeted protein degrader drugs. In addition, experts also share perspectives on how to inform the selection and development of orally bioavailable…
Optimizing Highly Potent API Drug Development and Manufacturing
Summary: This eBook explores the challenges and strategies involved in developing and manufacturing HPAPIs as well as highlights the benefits of partnering with an experienced CDMO that can effectively address the challenges of manufacturing potent drugs and…
Achieving Desired Particle Size and Yield Through Efficient Micronization
Summary: During this webinar learn with the right combination of technology and expertise, micronization can help to overcome many of the challenges faced by small molecule drugs and address the challenges and solutions to scale, yield and cost of goods.
Preclinical Toxicology vs Clinical: Key Considerations in Using Lipid-based Formulations
Summary: In this webinar, experts offer insights into the perceived barriers to developing LBFs and recent advances in translating them into useful clinical and commercial products of lipophilic drugs.